Application
p21WAF1 Antibody (Center H450) western blot analysis in WiDr cell line lysates (35ug/lane).This demonstrates the p21WAF1 antibody detected the p21WAF1 protein (arrow).| Product Name | p21WAF1 Antibody (Center H450) |
|---|---|
| Antibody Type | Primary Antibodies |
| Antigen Alias | LCMT2; KIAA0547; TYW4; Leucine carboxyl methyltransferase 2; p21WAF1/CIP1 promoter-interacting protein; tRNA wybutosine-synthesizing protein 4 homolog |
| Clonality | Polyclonal |
|---|---|
| Isotype | Ig |
| Host Species | Rabbit |
| Tested Applications | WB |
| WB:1:100~500 |
|
| Species Reactivity | Human |
| Concentration | 1mg/ml |
| Gene Synonyms | KIAA0547 TYW4 |
|---|---|
| Alternative Names | LCMT2 KIAA0547 TYW4 Leucine carboxyl methyltransferase 2 p21WAF1/CIP1 promoter-interacting protein tRNA wybutosine-synthesizing protein 4 homolog |
| Molecular Weight(MW) | 75602 Da |
| Function | Probable S-adenosyl-L-methionine-dependent methyltransferase that acts as a component of the wybutosine biosynthesis pathway. Wybutosine is a hyper modified guanosine with a tricyclic base found at the 3'-position adjacent to the anticodon of eukaryotic phenylalanine tRNA (By similarity). May methylate the carboxyl group of leucine residues to form alpha- leucine ester residues |
| Tissue Specificity | This p21WAF1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 442-471 amino acids from the Central region of human p21WAF1. |
| Entrez Gene | 9836 |
|---|---|
| Nucleotide Accession | NP_055608.2 |
Application
p21WAF1 Antibody (Center H450) western blot analysis in WiDr cell line lysates (35ug/lane).This demonstrates the p21WAF1 antibody detected the p21WAF1 protein (arrow).| Application Notes | WB:1:100~500 |
|---|
| Form | Liquid |
|---|---|
| Storage Instructions | For short-term storage, store at 4° C. For long-term storage, aliquot and store at -20ºC or below. Avoid multiple freeze-thaw cycles. |
| Storage Buffer | Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification. |
